ALISertib in Patients with Extensive-Stage Small-Cell Lung Cancer: The Phase 2 ALISCA-Lung1 Study

被引：0
作者：
Owonikoko, T. [1 ]
Burns, T. F. [2 ]
Chiappori, A. A. [3 ]
Drapkin, B. [4 ]
Gentzler, R. D. [5 ]
Goldschmidt, J. [6 ]
Hakimian, D. [7 ]
Jotte, R. [8 ]
Liu, S. V. [9 ]
Onitilo, A. A. [10 ]
Pennell, N. A. [11 ]
Potugari, B. [12 ]
Rios, J. [13 ]
Sands, J. [14 ]
Spira, A. [15 ]
Wang, B. [16 ]
Waterhouse, D. M. [17 ]
Lowenthal, B. [18 ]
Bebchuk, J. [18 ]
Eli, L. D. [18 ]
Wong, E. K. [18 ]
Dowlati, A. [19 ]
机构：
[1] Univ Maryland, Baltimore, MD USA
[2] UPMC Hillman Canc Ctr, Pittsburgh, PA USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[4] Univ Texas SouthWestern Med Ctr, Dallas, TX USA
[5] Univ Virginia, Charlottesville, VA USA
[6] US Oncol, Blue Ridge Canc Ctr, Blacksburg, VA USA
[7] US Oncol, Illinois Canc Specialists, Niles, IL USA
[8] Rocky Mt Canc Ctr, Lone Tree, CO USA
[9] Georgetown Univ, Washington, DC USA
[10] Marshfield Clin Wisconsin, Rapids, WI USA
[11] Cleveland Clin, Cleveland, OH USA
[12] Henry Ford Hosp, Detroit, MI USA
[13] Sarah Cannon Zangmeister Canc Ctr Columbus, Columbus, OH USA
[14] Dana Faber Canc Inst, Boston, MA USA
[15] Virginia Canc Specialists Res Inst, Fairfax, VA USA
[16] Willamette Valley Canc Inst & Res Ctr, Eugene, OR USA
[17] OHC Oncol Hematol Care, Cincinnati, OH USA
[18] Puma Biotechnol, Los Angeles, CA USA
[19] Univ Hosp Cleveland Med Ctr, Cleveland, OH USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
Alisertib; Small-cell lung cancer; Aurora kinase A inhibitor;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.13A.13
引用
收藏
页码：S212 / S213
页数：2
相关论文
共 50 条
  • [31] Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study
    Xie, Mingchao
    Vuko, Miljenka
    Rodriguez-Canales, Jaime
    Zimmermann, Johannes
    Schick, Markus
    O'Brien, Cathy
    Paz-Ares, Luis
    Goldman, Jonathan W.
    Garassino, Marina Chiara
    Gay, Carl M.
    Heymach, John V.
    Jiang, Haiyi
    Barrett, J. Carl
    Stewart, Ross A.
    Lai, Zhongwu
    Byers, Lauren A.
    Rudin, Charles M.
    Shrestha, Yashaswi
    MOLECULAR CANCER, 2024, 23 (01)
  • [32] Anlotinib as Maintenance Therapy for Extensive-stage Small-cell Lung Cancer: A Single-arm, Prospective, Phase II Study
    Kong, F.
    Wang, Z.
    Wang, N.
    Zhang, D.
    Liao, D.
    Zhang, J.
    Su, C.
    Jia, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S691 - S692
  • [33] The Efficacy and Toxicity of Lobaplatin-contained Chemotherapy in Extensive-stage Small-cell Lung Cancer
    Zhou, Ning-ning
    Zhou, Yuan-yuan
    Zhai, Lin-zhu
    Ruan, Chao-mei
    Yang, Yun-peng
    Huang, Yan
    Hou, Xue
    Chen, Li-kun
    Zhou, Ting
    Zhang, Li
    JOURNAL OF CANCER, 2018, 9 (13): : 2232 - 2236
  • [34] Thoracic radiotherapy for extensive-stage small-cell lung cancer: what is the optimal dose and timing?
    Yavas, Guler
    Yavas, Cagdas
    JOURNAL OF RADIATION ONCOLOGY, 2019, 8 (03) : 251 - 258
  • [35] Serplulimab monotherapy in extensive-stage small-cell lung cancer with brain metastasis: a case report
    Xiang, Xudong
    Li, Heng
    Lei, Bao
    Chen, Benchao
    Li, Gaofeng
    IMMUNOTHERAPY, 2024, 16 (08) : 521 - 527
  • [36] Mathematical optimisation of the cisplatin plus etoposide combination for managing extensive-stage small-cell lung cancer patients
    C Faivre
    R El Cheikh
    D Barbolosi
    F Barlesi
    British Journal of Cancer, 2017, 116 : 344 - 348
  • [37] Phase 1b study of ramucirumab in combination with irinotecan plus cisplatin in chemo-naive patients with extensive-stage small-cell lung cancer
    Kenmotsu, Hirotsugu
    Mori, Keita
    Mizuno, Risa
    Mamesaya, Nobuaki
    Kobayashi, Haruki
    Omori, Shota
    Wakuda, Kazushige
    Ono, Akira
    Naito, Tateaki
    Murakami, Haruyasu
    Takahashi, Toshiaki
    LUNG CANCER, 2022, 164 : 39 - 45
  • [38] Mathematical optimisation of the cisplatin plus etoposide combination for managing extensive-stage small-cell lung cancer patients
    Faivre, C.
    El Cheikh, R.
    Barbolosi, D.
    Barlesi, F.
    BRITISH JOURNAL OF CANCER, 2017, 116 (03) : 344 - 348
  • [39] Phase II trial with carboplatin and bendamustine in patients with extensive stage small-cell lung cancer
    Koester, Wolf
    Heider, Andrea
    Niederle, Norbert
    Wilke, Hansjochen
    Stamatis, Georgios
    Fischer, Juergen R.
    Koch, Jens A.
    Stahl, Michael
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (04) : 312 - 316
  • [40] Lurbinectedin in extensive-stage small-cell lung cancer: a brief report of the IFCT-2105 LURBICLIN study
    Girard, N.
    Guisier, F.
    Swalduz, A.
    Van Hulst, S.
    Pichon, E.
    Lavaud, P.
    Greillier, L.
    Tiotiu, A.
    Madroszyk, A.
    Bylicki, O.
    Canellas, A.
    Belmont, L.
    Zysman, M.
    Hauss, P. -a.
    Godbert, B.
    Audigier-Valette, C.
    Lebreton, C.
    Morin, F.
    Westeel, V.
    ESMO OPEN, 2024, 9 (12)
12345